Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2017-08-10
2018-02-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Consumption of Pecan-enriched Meal
NCT04849962
The Metabolic Effect of Walnuts in Healthy Subjects
NCT02329067
Postprandial Effects of Walnut Components Versus Whole Walnuts on Cardiovascular Disease (CVD) Risk Reduction
NCT00938340
The Measured Energy Value of Walnuts in the Human Diet
NCT01832909
Particle Sizing of Masticated Tree Nuts - Cashews and Walnuts
NCT02398084
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypothesis: The walnut-containing meals would mitigate post-meal increases in glucose, insulin, triglycerides (TG), and lipid peroxidation while improving all measures of subjective appetite and TAC compared to the traditional meal without nuts.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Participants in this group received a traditional muffin with butter as the predominant source of fat.
Control
Participants in this group received a traditional muffin with butter as the predominant source of fat.
Black walnut
Participants in this group received a muffin in which part of the butter was substituted out for black walnuts.
Black walnut
Participants in this group received a muffin in which part of the butter was substituted out for black walnuts.
English Walnut
Participants in this group received a muffin in which part of the butter was substituted out for English walnuts.
English walnut
Participants in this group received a muffin in which part of the butter was substituted out for English walnuts.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control
Participants in this group received a traditional muffin with butter as the predominant source of fat.
Black walnut
Participants in this group received a muffin in which part of the butter was substituted out for black walnuts.
English walnut
Participants in this group received a muffin in which part of the butter was substituted out for English walnuts.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal-weight (body mass index = 18-24.9kg/m2)
Exclusion Criteria
* Medication/supplement usage
* Chronic disease
* Pregnancy or plans to become pregnant
* Special diets
* Tobacco use
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Georgia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jamie Cooper, PhD
Professor and Director of UGA Obesity Initiative
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chad M Paton, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Georgia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Georgia - Department of Foods and Nutrition & Department of Food Science and Technology
Athens, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AWD00006706
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.